Cancer immunotherapy, a pivotal shift in combating cancer, harnesses the immune system to target malignant cells. Although it ...
Telomir Pharmaceuticals (TELO) reported new preclinical data from an in vivo study in mice bearing human aggressive prostate cancer tumors ...
Cancer thrives by hijacking the body's own basic survival systems, making it hard to attack tumors without collateral damage ...
New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer.
Researchers at the Institut Pasteur and Inserm have developed a novel triple-therapy that reprograms how B cell cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback